Granado. Miriam M; Martín. Ana Isabel AI; López-Menduiña. María M; López-Ca...
In rats given a bacterial toxin that normally hurts the liver, the peptide GHRP-2 (a ghrelin‑like compound) lowered liver enzymes, reduced harmful nitric oxide, cut down inflammatory TNF‑alpha, and boosted IGF‑I levels, indicating it protected the liver. The effect seemed to come from actions on liver support cells rather than the liver cells themselves.
Johansen. P B PB; Hansen. K T KT; Andersen. J V JV; Johansen. N L NL
In rats, the peptide ipamorelin and related growth‑hormone‑releasing peptides stay in the blood longer than GHRP‑6 and are mostly cleared in urine. When sprayed into the nose, about 20% of ipamorelin and roughly 50% of GHRP‑2 get into the bloodstream, showing that nasal delivery can work for these peptides.
Veldhuis. Johannes D JD; Keenan. Daniel M DM; Bowers. Cyril Y CY
The study shows that in healthy women, getting older sharply cuts down how much growth hormone (GH) is released in bursts, even when estrogen levels are kept constant. Both single shots and continuous infusions of GHRP‑2 (a GH‑releasing peptide) produce much smaller GH spikes in post‑menopausal women compared to younger women.
Arvat. E E; Di Vito. L L; Lanfranco. F F; Broglio. F F; Giordano. R R; Benso. A A; Muccioli. G P GP;...
In a small study of healthy volunteers, the synthetic octapeptide Tyr‑Ala‑HEX boosted growth hormone (GH) just as well as the known GH‑secretagogues Hexarelin and GHRP‑2, and it also raised prolactin, ACTH, and cortisol to similar levels. This shows Tyr‑Ala‑HEX works like the other peptides but the study used an IV dose (2 µg/kg) that isn’t typical for everyday use.
Tschöp. Matthias M; Statnick. Michael A MA; Suter. Todd M TM; Heiman. Mark L ML
In mice, the ghrelin‑like peptide GHRP‑2 makes you eat more and store extra fat even when a key appetite hormone (NPY) is missing. The weight gain seems to be driven partly by another brain protein called AGRP. This shows that ghrelin‑receptor drugs can push the body into a positive energy balance and could be useful for conditions where people lose weight, but the study is in rodents, not humans.
Veldhuis. Johannes D JD; Keenan. Daniel M DM; Mielke. Kristi K; Miles. John M JM; Bowers. Cyril Y CY
In healthy older men, giving testosterone raises their natural GH and IGF‑1 levels, but it doesn't make the GH‑releasing peptide GHRP‑2 work any better. The peptide still boosts GH the same amount whether testosterone is present or not.
In sheep pituitary cells that make growth hormone, the peptide GHRP‑2 lowers a specific potassium current (Kir) by activating the PKA‑cAMP pathway, which makes the cells more electrically active and helps release growth hormone. This effect is blocked if PKA is inhibited, but not by blocking PKC.
Roh. S G SG; Nie. G Y GY; Loneragan. K K; Gertler. A A; Chen. C C
A lab study on sheep pituitary cells found that leptin, a hormone linked to body fat, lowers the cells' production of growth hormone (GH) and makes them less responsive to the usual GH‑stimulating signal (GHRH). At the same time, leptin increases the cells' sensitivity to GHRP‑2, a peptide that also triggers GH release, and actually boosts the GH response to GHRP‑2. This suggests GHRP‑2 might help offset the GH‑suppressing effects of high leptin levels.
Erickson. Dana D; Keenan. Daniel M DM; Mielke. Kristi K; Bradford. Kandace K; Bowers. Cyril Y CY; Mi...
The study shows that older (post‑menopausal) women have lower baseline growth hormone (GH) and a weaker GH boost when given GHRP‑2 (or other GH‑releasing combos), even when estrogen levels are kept the same. The drop isn’t because they have fewer GH bursts, but because each burst is smaller, and belly fat also explains part of the difference. In short, age, not just estrogen, makes the GH‑releasing effect of GHRP‑2 weaker.
Veldhuis. Johannes D JD; Keenan. Daniel M DM; Bowers. Cyril Y CY
The study shows that estrogen acting through peripheral estrogen‑receptor‑alpha changes the shape of growth‑hormone (GH) release bursts in women. Blocking this receptor or adding estrogen can lengthen or shorten how long a GH burst lasts, and the effect depends on which GH‑stimulating agent (like GHRP‑2) is used.
Salvatori. R R; Serpa. M G MG; Parmigiani. G G; Britto. A V O AV; Oliveira. J L M JL; Oliveira. C R...
Even people who completely lack the normal growth‑hormone‑releasing hormone (GHRH) receptor still show a tiny but real rise in GH when given GHRP‑2 or when they experience a low‑blood‑sugar challenge. Clonidine, another GH‑stimulating drug, didn’t work in these patients.
Bowers. Cyril Y CY; Granda. Ramona R; Mohan. Subburaman S; Kuipers. Jonathan J; Baylink. David D; Ve...
In healthy older men and women, a 30‑day continuous sub‑cutaneous infusion of the peptide GHRP‑2 at a low dose (about 1 µg per kg body weight per hour) kept growth hormone pulses high and raised IGF‑I and its binding proteins, without any safety problems. The study also showed that giving GHRP‑2 together with GHRH works better than either alone, especially in older women.
Veldhuis. Johannes D JD; Cosma. Mihaela M; Erickson. Dana D; Paulo. Remberto R; Mielke. Kristi K; Fa...
The study shows that, even when estrogen levels are kept the same, older women (post‑menopausal) release far less growth hormone (GH) than younger women after being given GHRP‑2, GHRH, or arginine. Their GH response drops to about one‑third of that seen in younger women, and the usual ranking of which peptide works best (GHRP‑2 being strongest) disappears. More belly fat predicts a weaker GH boost from arginine, while higher IGF‑I levels predict a stronger response to GHRP‑2 and GHRH.
Veldhuis. Johannes D JD; Iranmanesh. Ali A; Bowers. Cyril Y CY
The study shows that as men get older, their bodies become less able to shut off growth hormone (GH) after a spike, which means the natural high‑amplitude GH bursts get weaker. In younger men, higher IGF‑I levels make this shut‑off stronger, leading to bigger GH pulses. The ghrelin‑mimic peptide GHRP‑2 can temporarily override this feedback, but its effect varies with age and IGF‑I levels.
Deghenghi. R R; Papotti. M M; Ghigo. E E; Muccioli. G G; Locatelli. V V
The study shows that some synthetic somatostatin drugs (like octreotide, lanreotide, and vapreotide) can bind to the same receptor in the pituitary that GHRP‑2 and other growth‑hormone‑releasing peptides use. Natural somatostatin itself does not do this, but the octapeptide versions do, meaning they could block or alter the effects of GHRP‑2.
Fintini. Danilo D; Alba. Maria M; Schally. Andrew V AV; Bowers. Cyril Y CY; Parlow. A F AF; Salvator...
In mice that lack the natural hormone that tells the pituitary to release growth hormone, giving a synthetic GHRH drug (JI-38) helped the pituitary grow, and adding the GHRP‑2 peptide on top made the animals taller and heavier than GHRH alone. However, GHRP‑2 by itself could not trigger a growth‑hormone spike unless some GHRH was present.
Anderson. S M SM; Wideman. L L; Patrie. J T JT; Weltman. A A; Bowers. C Y CY; Veldhuis. J D JD
A short 6‑23 day course of oral estradiol (E2) in post‑menopausal women made the growth‑hormone‑releasing peptide‑2 (GHRP‑2) trigger a bigger GH spike, even when the body’s normal feedback was trying to suppress GH. The effect was specific to GHRP‑2; estrogen didn’t change the response to GHRH or the body’s own GH pulses.
Anderson. S M SM; Shah. N N; Evans. W S WS; Patrie. J T JT; Bowers. C Y CY; Veldhuis. J D JD
In healthy post‑menopausal women, taking a short course of oral estradiol (about 2 mg per day for 1‑2 weeks) makes the body release a lot more growth hormone when a GHRP‑2 injection is given. The hormone boost is especially strong at higher GHRP‑2 doses, and the overall sensitivity to the peptide improves.
Kuriyama. H H; Hotta. M M; Wakabayashi. I I; Shibasaki. T T
In a rat study, continuously delivering the peptide KP-102 straight into the brain for six days made the animals eat more and gain weight, and it worked just as well even when the rats were exposed to stressful foot‑shocks.
The study shows that a short test using the brain hormone‑releasing factor GHRH together with a low dose of the synthetic peptide GHRP‑2 can safely trigger a measurable growth‑hormone (GH) surge. Compared to the traditional insulin tolerance test, this GHRH/GHRP‑2 combo is easier, has no side‑effects, and correctly identified GH‑deficient adults with about 79% sensitivity and perfect specificity at a cut‑off of 17 mU/L.